LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.42 | 17.25 | 962 | 3895 | 0.2469 | 0.6724 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.42 | 17.25 | 1762 | 3895 | 0.4523 | 0.8070 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.42 | 17.25 | 2 | 3895 | 0.0005 | -0.2409 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.42 | 17.25 | 2152 | 3895 | 0.5524 | 0.8538 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 46.39 | 17.25 | 1076 | 4141 | 0.2598 | 0.6866 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 46.39 | 17.25 | 1832 | 4141 | 0.4423 | 0.8040 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 46.39 | 17.25 | 2 | 4141 | 0.0005 | -0.2385 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 46.39 | 17.25 | 2326 | 4141 | 0.5616 | 0.8593 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 48.36 | 17.25 | 1543 | 4390 | 0.3515 | 0.7547 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 48.36 | 17.25 | 1972 | 4390 | 0.4492 | 0.8094 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 48.36 | 17.25 | 51 | 4390 | 0.0116 | 0.1453 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 48.36 | 17.25 | 2501 | 4390 | 0.5697 | 0.8640 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.33 | 17.25 | 1914 | 4651 | 0.4115 | 0.7917 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.33 | 17.25 | 2088 | 4651 | 0.4489 | 0.8112 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.33 | 17.25 | 151 | 4651 | 0.0325 | 0.3082 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.33 | 17.25 | 2628 | 4651 | 0.5650 | 0.8635 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.30 | 17.25 | 2085 | 4798 | 0.4345 | 0.8049 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.30 | 17.25 | 2199 | 4798 | 0.4583 | 0.8167 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.30 | 17.25 | 227 | 4798 | 0.0473 | 0.3735 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.30 | 17.25 | 2767 | 4798 | 0.5766 | 0.8689 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.27 | 17.25 | 2212 | 4884 | 0.4529 | 0.8147 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.27 | 17.25 | 2306 | 4884 | 0.4722 | 0.8240 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.27 | 17.25 | 510 | 4884 | 0.1044 | 0.5155 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.27 | 17.25 | 2905 | 4884 | 0.5948 | 0.8764 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.24 | 17.25 | 2383 | 4929 | 0.4835 | 0.8295 | MN20160310_N02 | C11 |